Yahoo Finance Have Insiders Been Selling USANA Health Sciences, Inc. (NYSE:USNA) Shares This Year?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we'll take a look at whether insiders have been buying or selling shares in USANA Health Sciences, Inc. (NYSE:USNA).
Do Insider Transactions Matter?
It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, most countries require that the company discloses such transactions to the market.
Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.
Check out our latest analysis for USANA Health Sciences
USANA Health Sciences Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider sale was by the Founder & Chairman of the Board, Myron Wentz, for US$46m worth of shares, at about US$118 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$70.78. So it may not tell us anything about how insiders feel about the current share price.
In the last twelve months insiders netted US$91m for 752k shares sold. Insiders in USANA Health Sciences didn't buy any shares in the last year. The chart below shows insider transactions (by individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Insiders at USANA Health Sciences Have Sold Stock Recently
Over the last three months, we've seen a bit of insider selling at USANA Health Sciences. Lead Independent Director Gilbert Fuller sold just US$24k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the selling simply isn't sufficiently substantial to be of much use as a signal.
Insider Ownership of USANA Health Sciences
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that USANA Health Sciences insiders own 42% of the company, worth about US$701m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
So What Does This Data Suggest About USANA Health Sciences Insiders?
We did not see any insider buying in the last three months, but we did see selling. But the sales were small, so we're not concerned. While we feel good about high insider ownership of USANA Health Sciences, we can't say the same about the selling of shares. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for USANA Health Sciences.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
